drugset / Trial / NCT02284672

The Effect of Dexmedetomidine on Propofol Requirement for Insertion of Laryngeal Mask Airway

NCT02284672 ↗

Phase 4 Completed 39 enrolled Ajou University School of Medicine
RandomizedParallel-groupDouble-blind

Summary

Propofol frequently used as an inducting medication for insertion Laryngeal mask airway(LMA). But propofol alone can be not sufficient for inhibiting upper airway reflex and also result in cardiovascular suppression under enough amount. Dexmedetomidine is a selective alplh2 receptor agonist with analgesic and sedative effects but sparing respiratory function. Therefore propofol combined with dexmedetomidine induction could be more effective in preserve respiration under same condition for LMA insertion than propofol alone. In this study, the investigators investigate the clinical dose of propofol for LMA insertion with premedication of dexmedetomidine, and evaluate the effect of dexmedetomidine.

Timeline

Start
2014-11
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified — —

Indications

No indication recorded.